Skip to content
Search

Latest Stories

Whooping cough cases on the rise in England, warns UKSHA

Whooping cough cases on the rise in England, warns UKSHA

The current increase has been linked to a steady decline in the uptake of maternal pertussis vaccine and childhood vaccinations

The UK Health Security Agency (UKHSA) has warned that there has been a continued increase in cases of whooping cough (pertussis) across England since the start of this year.


According to new data published by the agency on Thursday (7 March), 553 new cases of whooping cough were confirmed in January alone, compared with 858 cases for the whole of last year (2023).

The country is witnessing a surge in whooping cough cases after a prolonged period of low case numbers, attributed to restrictions and reduced social interaction during the COVID-19 pandemic. England recorded the highest number of whooping cough cases in 2016, recording 5,949 cases.

As the ongoing rise coincides with a steady decline in the vaccination rates among pregnant women and children, UKHSA has strongly encouraged mums-to-be to get the maternal pertussis vaccine so that their young baby is protected against this serious disease.

As per the data for January, 22 infants aged under 3 months were diagnosed with whooping cough. UKHSA warned that these infants, who are too young to be fully vaccinated, are at greater risk of severe disease, including death.

The agency emphasised that vaccinating pregnant women is 97 per cent effective in preventing death in young infants from whooping cough.

Dr Gayatri Amirthalingam, Consultant Epidemiologist at UKHSA, said: “Whooping cough can affect people of all ages but for very young infants, it can be particularly serious. However, vaccinating pregnant women is highly effective in protecting babies from birth until they can receive their own vaccines.

“Parents can also help protect their children by ensuring they receive their vaccines at the right time or catching up as soon as possible if they have missed any. If you’re unsure, please check your child’s red book or get in touch with your GP surgery.”

Steve Russell, National Director for Vaccinations and Screening at NHS England, has urged families come forward to get the protection they need.

“If you are pregnant and have not been vaccinated yet, or your child is not up-to-date with whooping cough or other routine vaccinations, please contact your GP as soon as possible, and if you or your child have symptoms ask for an urgent GP appointment or get help from NHS 111,” he said.

Parents are encouraged to ensure that their children are vaccinated against whooping cough. The vaccine is offered to all infants at 8, 12 and 16 weeks of age as part of the 6-in-1 combination vaccine, with an additional dose included in the pre-school booster vaccine.

The agency highlighted a consistent decrease in the uptake of all childhood vaccinations offered through the routine NHS programme in England over the past decade.

As of September 2023, the percentage of 2-year-olds who completed their 6-in-1 vaccinations stands at 92.9 per cent, a decrease from 96.3 per cent recorded in March 2014, as revealed by the agency.

Additionally, uptake of the maternal pertussis vaccine, offered to women in every pregnancy, has dropped from over 70 per cent in September 2017 to around 58 per cent in September 2023.

Know more about whooping cough

Clinically known as pertussis, it is a bacterial infection that affects the lungs. Initial symptoms of the infection are similar to those of a cold, including a runny nose and sore throat. However, after approximately a week, the infection may progress to bouts of coughing that can last for a few minutes, typically worse at night.

Young babies may exhibit a distinctive "whoop" sound or experience breathing difficulties after a bout of coughing.

People who are diagnosed with whooping cough are advised to stay at home and avoid going to work, school or nursery until 48 hours after starting antibiotics, or 3 weeks after symptoms start if they have not had antibiotics to prevent the spread of infection, especially to vulnerable groups.

However, UKHSA underscored that vaccination is the best protection for babies and children.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less